Biomarkers are objective indicators used to assess normal or pathological processes,
evaluate responses to treatment and predict outcomes. Many blood biomarkers already …

Background Searching for studies to include in a systematic review (SR) is a time-and labor-
intensive process with searches of multiple databases recommended. To reduce the time …

Background Failure to test for pulmonary embolism (PE) can be a lethal mistake, but PE and
produces symptoms similar to many other diseases. Overtesting for PE has negative …

Background Venous thromboembolism (VTE) is a frequent complication in critically ill
patients with coronavirus disease 2019 (COVID-19) and is associated with mortality. Early …

D-dimer, a soluble fibrin degradation product that originates from plasmin-induced
degradation of cross-linked fibrin, is an important biomarker of coagulation activation and …

Objectives To describe imaging and laboratory findings of confirmed PE diagnosed in
COVID-19 patients and to evaluate the characteristics of COVID-19 patients with clinical PE …

Context.—The clinical applications of point-of-care testing (POCT) are gradually increasing
in many health care systems. Recently, POCT devices using molecular genetic method …

Hemodynamic instability and right ventricular (RV) dysfunction are the key determinants of
short-term prognosis in patients with acute pulmonary embolism (PE). High-risk PE …

Objective This study seeks to evaluate the test characteristics of D‐dimer for pulmonary
embolism (PE) in patients with a concurrent diagnosis of COVID‐19. We hypothesized that …

The reverse transcription-polymerase chain reaction (RT-PCR) assay is the accepted
standard for coronavirus disease 2019 (COVID-19) diagnosis. As any test, RT-PCR provides …